Share Price and Basic Stock Data
Last Updated: January 29, 2026, 11:25 am
| PEG Ratio | 36.47 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vakrangee Ltd operates in the IT Consulting and Software industry, reporting a current stock price of ₹7.06 and a market capitalization of ₹761 Cr. The company has experienced fluctuating revenue, with sales reported at ₹234.07 Cr in September 2022, declining to ₹49.15 Cr by December 2022. A slight recovery ensued, with sales rising to ₹55.59 Cr by June 2023, but subsequently fell to ₹51.54 Cr in September 2023. For the most recent trailing twelve months (TTM), sales stood at ₹269 Cr, showing an upward trend compared to ₹197 Cr in March 2023. Despite this, the company’s historical sales have not returned to their peak levels, with a high of ₹6,502 Cr recorded in March 2018, followed by a significant decline in subsequent years due to operational challenges and market dynamics. This volatility in revenue indicates the need for strategic realignment to stabilize and enhance business performance.
Profitability and Efficiency Metrics
Vakrangee’s profitability metrics reveal a net profit of ₹10 Cr, translating to a net profit margin of 2.50% for the fiscal year ending March 2025. The company’s operating profit margin (OPM) stood at 10.52%, reflecting a marginal improvement from 9% in March 2023. The return on equity (ROE) is relatively low at 3.65%, suggesting that the company is not generating substantial returns for its shareholders compared to industry standards. The interest coverage ratio (ICR) is robust at 15.39x, indicating that Vakrangee can comfortably meet its interest obligations, which is a positive sign of financial health. However, the low ROE and net profit margins indicate inefficiencies in converting revenue into profit, highlighting an area for improvement. The company’s cash conversion cycle (CCC) of 45 days reflects operational efficiency, but the focus should be on enhancing profitability alongside maintaining operational performance.
Balance Sheet Strength and Financial Ratios
Vakrangee’s balance sheet shows a total asset value of ₹309 Cr, with total liabilities at ₹309 Cr, indicating a balanced financial structure. The company reported reserves of ₹100 Cr and borrowings of ₹4 Cr, showcasing a strong equity position with minimal debt, which enhances financial stability. The price-to-book value (P/BV) ratio is currently at 5.75x, indicating that the market values the company significantly higher than its book value, a potential signal of investor confidence. However, the low return on capital employed (ROCE) of 5.86% raises concerns about the efficiency of capital utilization. Moreover, the current ratio of 2.15x and quick ratio of 1.90x indicate good liquidity, ensuring that the company can meet its short-term obligations. While the balance sheet reflects strength in terms of low leverage and adequate liquidity, the company must enhance its capital efficiency to improve overall financial performance.
Shareholding Pattern and Investor Confidence
The shareholding structure of Vakrangee Ltd shows that promoters hold 40.05% of the equity, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold 0.83% and 4.47%, respectively. The public holds a significant 54.66%, indicating a broad base of retail investor support. Over the past year, promoter shareholding has gradually declined from 42.60% in March 2023, reflecting a potential dilution of control or strategic repositioning. The increase in public shareholding from 43.15% in December 2022 to the current level suggests growing investor confidence, despite the decline in institutional interest. The number of shareholders has also risen to 4,16,518, demonstrating increasing retail participation in the stock. This shift may indicate a shift in market sentiment towards the company, but the declining promoter stake could raise concerns about long-term strategic direction.
Outlook, Risks, and Final Insight
Looking ahead, Vakrangee faces several strengths and risks that may impact its future trajectory. Strengths include a solid interest coverage ratio of 15.39x, reflecting strong ability to service debt, and a diverse shareholder base that supports its market position. Risks include the low ROE of 3.65%, indicating inefficiencies in generating returns for investors, and the volatility in sales figures, which may signal ongoing operational challenges. Additionally, the reliance on a large public shareholder base could lead to volatility in stock performance. The company must navigate these dynamics carefully, focusing on enhancing profitability and operational efficiency while addressing investor concerns regarding management and strategic direction. If implemented effectively, Vakrangee could stabilize its revenue streams and improve its market standing, fostering long-term growth and shareholder value.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 55.8 Cr. | 17.7 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 133 Cr. | 123 | 194/99.8 | 20.3 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 54.4 Cr. | 425 | 425/140 | 34.0 | 26.7 | 0.24 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 7.93 Cr. | 1.47 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,973.32 Cr | 529.50 | 76.71 | 123.68 | 0.60% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 234.07 | 49.15 | 50.94 | 55.59 | 51.54 | 51.56 | 53.89 | 58.70 | 65.25 | 67.88 | 63.18 | 68.84 | 69.08 |
| Expenses | 224.43 | 44.15 | 46.22 | 48.97 | 45.62 | 45.33 | 46.28 | 52.14 | 60.01 | 62.40 | 56.35 | 61.02 | 61.81 |
| Operating Profit | 9.64 | 5.00 | 4.72 | 6.62 | 5.92 | 6.23 | 7.61 | 6.56 | 5.24 | 5.48 | 6.83 | 7.82 | 7.27 |
| OPM % | 4.12% | 10.17% | 9.27% | 11.91% | 11.49% | 12.08% | 14.12% | 11.18% | 8.03% | 8.07% | 10.81% | 11.36% | 10.52% |
| Other Income | 1.36 | -0.05 | 0.86 | 0.31 | 0.87 | 1.32 | 0.39 | 0.89 | 0.82 | 0.75 | 1.55 | 1.51 | 1.64 |
| Interest | 0.00 | 0.00 | 1.52 | 1.99 | 1.83 | 1.93 | 1.96 | 0.45 | 0.60 | 0.38 | 0.40 | 0.36 | 0.35 |
| Depreciation | 4.19 | 4.01 | 3.39 | 3.95 | 3.97 | 3.92 | 3.85 | 3.89 | 4.28 | 4.24 | 4.29 | 4.30 | 4.45 |
| Profit before tax | 6.81 | 0.94 | 0.67 | 0.99 | 0.99 | 1.70 | 2.19 | 3.11 | 1.18 | 1.61 | 3.69 | 4.67 | 4.11 |
| Tax % | 29.22% | 86.17% | -1.49% | 49.49% | 57.58% | 26.47% | 0.00% | 27.97% | 50.85% | 35.40% | 31.71% | 28.91% | 26.28% |
| Net Profit | 4.82 | 0.13 | 0.68 | 0.49 | 0.42 | 1.24 | 2.19 | 2.24 | 0.59 | 1.04 | 2.52 | 3.32 | 3.03 |
| EPS in Rs | 0.05 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 |
Last Updated: December 28, 2025, 3:31 pm
Below is a detailed analysis of the quarterly data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 69.08 Cr.. The value appears strong and on an upward trend. It has increased from 68.84 Cr. (Jun 2025) to 69.08 Cr., marking an increase of 0.24 Cr..
- For Expenses, as of Sep 2025, the value is 61.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 61.02 Cr. (Jun 2025) to 61.81 Cr., marking an increase of 0.79 Cr..
- For Operating Profit, as of Sep 2025, the value is 7.27 Cr.. The value appears to be declining and may need further review. It has decreased from 7.82 Cr. (Jun 2025) to 7.27 Cr., marking a decrease of 0.55 Cr..
- For OPM %, as of Sep 2025, the value is 10.52%. The value appears to be declining and may need further review. It has decreased from 11.36% (Jun 2025) to 10.52%, marking a decrease of 0.84%.
- For Other Income, as of Sep 2025, the value is 1.64 Cr.. The value appears strong and on an upward trend. It has increased from 1.51 Cr. (Jun 2025) to 1.64 Cr., marking an increase of 0.13 Cr..
- For Interest, as of Sep 2025, the value is 0.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.36 Cr. (Jun 2025) to 0.35 Cr., marking a decrease of 0.01 Cr..
- For Depreciation, as of Sep 2025, the value is 4.45 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.30 Cr. (Jun 2025) to 4.45 Cr., marking an increase of 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 4.11 Cr.. The value appears to be declining and may need further review. It has decreased from 4.67 Cr. (Jun 2025) to 4.11 Cr., marking a decrease of 0.56 Cr..
- For Tax %, as of Sep 2025, the value is 26.28%. The value appears to be improving (decreasing) as expected. It has decreased from 28.91% (Jun 2025) to 26.28%, marking a decrease of 2.63%.
- For Net Profit, as of Sep 2025, the value is 3.03 Cr.. The value appears to be declining and may need further review. It has decreased from 3.32 Cr. (Jun 2025) to 3.03 Cr., marking a decrease of 0.29 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.03. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.03.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,952 | 2,780 | 3,191 | 4,000 | 6,502 | 1,508 | 685 | 314 | 194 | 197 | 213 | 255 | 269 |
| Expenses | 1,417 | 2,057 | 2,370 | 3,054 | 5,495 | 1,530 | 661 | 286 | 176 | 179 | 186 | 231 | 242 |
| Operating Profit | 535 | 723 | 821 | 946 | 1,007 | -22 | 24 | 28 | 18 | 19 | 26 | 24 | 27 |
| OPM % | 27% | 26% | 26% | 24% | 15% | -1% | 3% | 9% | 9% | 9% | 12% | 9% | 10% |
| Other Income | 6 | 6 | 6 | 5 | 34 | 82 | 83 | 70 | 2 | 1 | 3 | 4 | 5 |
| Interest | 78 | 75 | 56 | 50 | 10 | 0 | 0 | 0 | 0 | 2 | 8 | 2 | 1 |
| Depreciation | 181 | 165 | 164 | 73 | 7 | 9 | 15 | 15 | 15 | 16 | 16 | 17 | 17 |
| Profit before tax | 282 | 489 | 606 | 828 | 1,024 | 51 | 92 | 83 | 5 | 3 | 6 | 10 | 14 |
| Tax % | 38% | 34% | 35% | 36% | 34% | 51% | 22% | 24% | 100% | 63% | 26% | 33% | |
| Net Profit | 175 | 322 | 395 | 531 | 680 | 25 | 71 | 63 | 0 | 1 | 4 | 6 | 10 |
| EPS in Rs | 1.74 | 3.20 | 3.73 | 5.02 | 6.43 | 0.24 | 0.67 | 0.59 | 0.00 | 0.01 | 0.04 | 0.06 | 0.09 |
| Dividend Payout % | 7% | 4% | 17% | 20% | 4% | 105% | 37% | 17% | 530% | 122% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 84.00% | 22.67% | 34.43% | 28.06% | -96.32% | 184.00% | -11.27% | -100.00% | 300.00% | 50.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -61.33% | 11.76% | -6.37% | -124.38% | 280.32% | -195.27% | -88.73% | 400.00% | -250.00% |
Vakrangee Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -21% |
| 5 Years: | -18% |
| 3 Years: | 10% |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -37% |
| 3 Years: | % |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -16% |
| 5 Years: | -19% |
| 3 Years: | -34% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 4% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 50 | 50 | 53 | 53 | 106 | 106 | 106 | 106 | 106 | 106 | 106 | 108 | 108 |
| Reserves | 729 | 1,157 | 1,530 | 2,001 | 2,487 | 2,496 | 2,531 | 2,558 | 22 | 18 | 56 | 94 | 100 |
| Borrowings | 492 | 416 | 320 | 144 | 0 | 0 | 0 | 0 | 27 | 58 | 12 | 5 | 4 |
| Other Liabilities | 453 | 414 | 189 | 71 | 400 | 116 | 182 | 212 | 178 | 116 | 126 | 102 | 130 |
| Total Liabilities | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
| Fixed Assets | 436 | 273 | 132 | 29 | 90 | 143 | 149 | 156 | 139 | 127 | 114 | 110 | 119 |
| CWIP | 48 | 10 | 0 | 0 | 3 | 13 | 5 | 5 | 6 | 8 | 10 | 17 | 9 |
| Investments | 3 | 2 | 2 | 2 | 29 | 4 | 3 | 1 | 2 | 3 | 7 | 4 | 5 |
| Other Assets | 1,238 | 1,753 | 1,959 | 2,238 | 2,871 | 2,558 | 2,662 | 2,714 | 186 | 160 | 169 | 177 | 210 |
| Total Assets | 1,725 | 2,037 | 2,092 | 2,268 | 2,993 | 2,718 | 2,819 | 2,876 | 333 | 298 | 300 | 309 | 343 |
Below is a detailed analysis of the balance sheet data for Vakrangee Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 108.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 108.00 Cr..
- For Reserves, as of Sep 2025, the value is 100.00 Cr.. The value appears strong and on an upward trend. It has increased from 94.00 Cr. (Mar 2025) to 100.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 4.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2025) to 4.00 Cr., marking a decrease of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 130.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 102.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 28.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 343.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 119.00 Cr.. The value appears strong and on an upward trend. It has increased from 110.00 Cr. (Mar 2025) to 119.00 Cr., marking an increase of 9.00 Cr..
- For CWIP, as of Sep 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 8.00 Cr..
- For Investments, as of Sep 2025, the value is 5.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 5.00 Cr., marking an increase of 1.00 Cr..
- For Other Assets, as of Sep 2025, the value is 210.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2025) to 210.00 Cr., marking an increase of 33.00 Cr..
- For Total Assets, as of Sep 2025, the value is 343.00 Cr.. The value appears strong and on an upward trend. It has increased from 309.00 Cr. (Mar 2025) to 343.00 Cr., marking an increase of 34.00 Cr..
Notably, the Reserves (100.00 Cr.) exceed the Borrowings (4.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 43.00 | 307.00 | 501.00 | 802.00 | 1.00 | -22.00 | 24.00 | 28.00 | -9.00 | -39.00 | 14.00 | 19.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 144 | 157 | 97 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 39 |
| Inventory Days | 45 | 31 | 81 | 223 | ||||||||
| Days Payable | 71 | 39 | 18 | 217 | ||||||||
| Cash Conversion Cycle | 119 | 149 | 160 | 75 | 73 | 319 | 729 | 1,301 | 79 | 74 | 75 | 45 |
| Working Capital Days | 66 | 124 | 137 | 129 | 55 | 310 | 894 | 2,188 | -145 | -53 | -6 | 4 |
| ROCE % | 31% | 39% | 37% | 43% | 43% | 2% | 3% | 3% | 0% | 3% | 7% | 6% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Diluted EPS (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| Cash EPS (Rs.) | 0.21 | 0.18 | 0.15 | 1.18 | 0.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.64 | 1.14 | 1.17 | 25.93 | 25.15 |
| Revenue From Operations / Share (Rs.) | 2.35 | 2.01 | 1.86 | 7.35 | 2.97 |
| PBDIT / Share (Rs.) | 0.25 | 0.27 | 0.18 | 1.50 | 0.92 |
| PBIT / Share (Rs.) | 0.10 | 0.12 | 0.03 | 1.35 | 0.78 |
| PBT / Share (Rs.) | 0.08 | 0.05 | 0.02 | 1.34 | 0.78 |
| Net Profit / Share (Rs.) | 0.05 | 0.04 | 0.01 | 1.03 | 0.59 |
| NP After MI And SOA / Share (Rs.) | 0.06 | 0.04 | 0.01 | 1.03 | 0.59 |
| PBDIT Margin (%) | 11.02 | 13.51 | 9.98 | 20.37 | 31.06 |
| PBIT Margin (%) | 4.48 | 6.12 | 2.12 | 18.39 | 26.35 |
| PBT Margin (%) | 3.76 | 2.75 | 1.35 | 18.17 | 26.35 |
| Net Profit Margin (%) | 2.50 | 2.04 | 0.50 | 14.06 | 19.97 |
| NP After MI And SOA Margin (%) | 2.61 | 2.04 | 0.50 | 14.06 | 19.97 |
| Return on Networth / Equity (%) | 3.75 | 3.61 | 0.81 | 3.98 | 2.35 |
| Return on Capital Employeed (%) | 4.85 | 6.92 | 2.68 | 5.20 | 3.10 |
| Return On Assets (%) | 2.15 | 1.45 | 0.33 | 3.73 | 2.18 |
| Long Term Debt / Equity (X) | 0.00 | 0.06 | 0.10 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.10 | 0.46 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.83 | 0.71 | 0.10 | 0.24 | 0.08 |
| Current Ratio (X) | 2.15 | 1.40 | 1.05 | 11.93 | 10.20 |
| Quick Ratio (X) | 1.90 | 1.40 | 1.04 | 11.90 | 10.17 |
| Inventory Turnover Ratio (X) | 26.84 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 81.17 | 121.71 | 527.21 | 9.67 | 42.17 |
| Dividend Payout Ratio (CP) (%) | 23.13 | 26.43 | 32.07 | 8.47 | 34.13 |
| Earning Retention Ratio (%) | 18.83 | -21.71 | -427.21 | 90.33 | 57.83 |
| Cash Earning Retention Ratio (%) | 76.87 | 73.57 | 67.93 | 91.53 | 65.87 |
| Interest Coverage Ratio (X) | 15.39 | 3.72 | 13.01 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 4.50 | 1.49 | 1.66 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 947.72 | 2066.51 | 1718.30 | 3625.04 | 5916.69 |
| EV / Net Operating Revenue (X) | 3.72 | 9.72 | 8.71 | 4.66 | 18.83 |
| EV / EBITDA (X) | 33.70 | 71.95 | 87.18 | 22.84 | 60.61 |
| MarketCap / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| Retention Ratios (%) | 18.82 | -21.71 | -427.21 | 90.32 | 57.82 |
| Price / BV (X) | 5.75 | 17.47 | 13.70 | 1.34 | 2.23 |
| Price / Net Operating Revenue (X) | 4.00 | 9.89 | 8.60 | 4.73 | 18.89 |
| EarningsYield | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
After reviewing the key financial ratios for Vakrangee Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 0.21, marking an increase of 0.03.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 1.64. It has increased from 1.14 (Mar 24) to 1.64, marking an increase of 0.50.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2.35. It has increased from 2.01 (Mar 24) to 2.35, marking an increase of 0.34.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 2. It has decreased from 0.27 (Mar 24) to 0.25, marking a decrease of 0.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.10. This value is within the healthy range. It has decreased from 0.12 (Mar 24) to 0.10, marking a decrease of 0.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.08. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.08, marking an increase of 0.03.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 2. It has increased from 0.04 (Mar 24) to 0.06, marking an increase of 0.02.
- For PBDIT Margin (%), as of Mar 25, the value is 11.02. This value is within the healthy range. It has decreased from 13.51 (Mar 24) to 11.02, marking a decrease of 2.49.
- For PBIT Margin (%), as of Mar 25, the value is 4.48. This value is below the healthy minimum of 10. It has decreased from 6.12 (Mar 24) to 4.48, marking a decrease of 1.64.
- For PBT Margin (%), as of Mar 25, the value is 3.76. This value is below the healthy minimum of 10. It has increased from 2.75 (Mar 24) to 3.76, marking an increase of 1.01.
- For Net Profit Margin (%), as of Mar 25, the value is 2.50. This value is below the healthy minimum of 5. It has increased from 2.04 (Mar 24) to 2.50, marking an increase of 0.46.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.61. This value is below the healthy minimum of 8. It has increased from 2.04 (Mar 24) to 2.61, marking an increase of 0.57.
- For Return on Networth / Equity (%), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 15. It has increased from 3.61 (Mar 24) to 3.75, marking an increase of 0.14.
- For Return on Capital Employeed (%), as of Mar 25, the value is 4.85. This value is below the healthy minimum of 10. It has decreased from 6.92 (Mar 24) to 4.85, marking a decrease of 2.07.
- For Return On Assets (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 5. It has increased from 1.45 (Mar 24) to 2.15, marking an increase of 0.70.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.00, marking a decrease of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.10 (Mar 24) to 0.00, marking a decrease of 0.10.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.83. It has increased from 0.71 (Mar 24) to 0.83, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 2.15, marking an increase of 0.75.
- For Quick Ratio (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has increased from 1.40 (Mar 24) to 1.90, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 26.84. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 26.84, marking an increase of 26.84.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 81.17. This value exceeds the healthy maximum of 50. It has decreased from 121.71 (Mar 24) to 81.17, marking a decrease of 40.54.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 23.13. This value is within the healthy range. It has decreased from 26.43 (Mar 24) to 23.13, marking a decrease of 3.30.
- For Earning Retention Ratio (%), as of Mar 25, the value is 18.83. This value is below the healthy minimum of 40. It has increased from -21.71 (Mar 24) to 18.83, marking an increase of 40.54.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 76.87. This value exceeds the healthy maximum of 70. It has increased from 73.57 (Mar 24) to 76.87, marking an increase of 3.30.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 15.39. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 15.39, marking an increase of 11.67.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.50. This value is within the healthy range. It has increased from 1.49 (Mar 24) to 4.50, marking an increase of 3.01.
- For Enterprise Value (Cr.), as of Mar 25, the value is 947.72. It has decreased from 2,066.51 (Mar 24) to 947.72, marking a decrease of 1,118.79.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.72. This value exceeds the healthy maximum of 3. It has decreased from 9.72 (Mar 24) to 3.72, marking a decrease of 6.00.
- For EV / EBITDA (X), as of Mar 25, the value is 33.70. This value exceeds the healthy maximum of 15. It has decreased from 71.95 (Mar 24) to 33.70, marking a decrease of 38.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For Retention Ratios (%), as of Mar 25, the value is 18.82. This value is below the healthy minimum of 30. It has increased from -21.71 (Mar 24) to 18.82, marking an increase of 40.53.
- For Price / BV (X), as of Mar 25, the value is 5.75. This value exceeds the healthy maximum of 3. It has decreased from 17.47 (Mar 24) to 5.75, marking a decrease of 11.72.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.00. This value exceeds the healthy maximum of 3. It has decreased from 9.89 (Mar 24) to 4.00, marking a decrease of 5.89.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vakrangee Ltd:
- Net Profit Margin: 2.5%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 4.85% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 3.75% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.5
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 63.4 (Industry average Stock P/E: 76.71)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.5%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Vakrangee Corporate House, Plot No 93, Road No. 16, Mumbai Maharashtra 400093 | info@vakrangee.in http://www.vakrangee.in |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Divya Nandwana | Executive Chairperson |
| Mr. Vedant Nandwana | Managing Director |
| Mr. Hari Chand Mittal | Ind. Non-Executive Director |
| Ms. Savita Keni | Independent Director |
| Mr. L K Shamsunder | Non Exe.Non Ind. & Nominee Director |
| Mr. Sandeep Gaware | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Vakrangee Ltd?
Vakrangee Ltd's intrinsic value (as of 29 January 2026) is ₹3.70 which is 45.91% lower the current market price of ₹6.84, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹741 Cr. market cap, FY2025-2026 high/low of ₹27.3/6.21, reserves of ₹100 Cr, and liabilities of ₹343 Cr.
What is the Market Cap of Vakrangee Ltd?
The Market Cap of Vakrangee Ltd is 741 Cr..
What is the current Stock Price of Vakrangee Ltd as on 29 January 2026?
The current stock price of Vakrangee Ltd as on 29 January 2026 is ₹6.84.
What is the High / Low of Vakrangee Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vakrangee Ltd stocks is ₹27.3/6.21.
What is the Stock P/E of Vakrangee Ltd?
The Stock P/E of Vakrangee Ltd is 63.4.
What is the Book Value of Vakrangee Ltd?
The Book Value of Vakrangee Ltd is 1.93.
What is the Dividend Yield of Vakrangee Ltd?
The Dividend Yield of Vakrangee Ltd is 0.00 %.
What is the ROCE of Vakrangee Ltd?
The ROCE of Vakrangee Ltd is 5.86 %.
What is the ROE of Vakrangee Ltd?
The ROE of Vakrangee Ltd is 3.65 %.
What is the Face Value of Vakrangee Ltd?
The Face Value of Vakrangee Ltd is 1.00.